Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Ann Allergy Asthma Immunol ; 109(6): 442-7, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23176885

RESUMEN

BACKGROUND: An understanding of the mechanisms responsible for the development and maintenance of allergic inflammation and their clinical implications is needed to develop specific and successful treatment for allergy. OBJECTIVES: To characterize in vitro T-cell responses to Der p 2, one of the major allergens of house dust mite (HDM), and investigate potential correlations between clinical and laboratory parameters. METHODS: Forty-two patients monosensitized to HDM and 10 age-matched, healthy children were studied. Dendritic cells pulsed with Der p 2 were used to stimulate autologous CD14(-) cells. Der p 2-specific T-cell activation markers, proliferation, and cytokine production profiles were examined. RESULTS: Der p 2-specific T-cell activation markers, proliferation, and T(H)2 cytokine production were significantly higher in HDM patients compared with healthy controls. Moreover, a significant correlation between proliferation and T(H)2 cytokine production was observed. Within the allergic group, skin reaction to HDM was significantly stronger in patients with a Der p 2-specific T-cell response. Levels of HDM-specific IgE directly correlated with interleukin 5 and interleukin 13 levels and with skin prick test results and, ultimately, with the patient's family history of allergy. Furthermore, the presence of atopic march correlated with T-cell proliferation. CONCLUSION: We found that, in HDM patients, Der p 2-specific T(H)2 responses, promoted by autologous dendritic cells in vitro, correlate with clinical parameters.


Asunto(s)
Alérgenos/inmunología , Antígenos Dermatofagoides/inmunología , Proteínas de Artrópodos/inmunología , Hipersensibilidad/inmunología , Pyroglyphidae/inmunología , Células Th2/inmunología , Adolescente , Animales , Biomarcadores , Estudios de Casos y Controles , Proliferación Celular , Niño , Preescolar , Citocinas/inmunología , Células Dendríticas/inmunología , Femenino , Humanos , Inmunoglobulina E/inmunología , Leucocitos Mononucleares/inmunología , Activación de Linfocitos/inmunología , Masculino , Pruebas Cutáneas/métodos
2.
J Asthma ; 48(4): 419-26, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21410425

RESUMEN

BACKGROUND: To investigate whether an active partnership between schools, parents, and pediatricians can improve the management of asthma and quality of life of children with asthma. METHODS: A comprehensive asthma program (Happy Air®), based on a strong family-physician-school relationship, was carried out over a period of 3 years in six primary schools (2765 children). This program provides educational intervention to families, school staff, and students, as well as the administration of written questionnaires to identify children with asthma, asthma diagnosis and management, and, last but not least, extracurricular activities to improve respiratory and psychological conditions. Quality of life of children and parents, at the beginning and end of the program, was assessed using PedsQL™ 4.0 (Pediatric Quality of Life Inventory) measurement model. RESULT: Asthma was diagnosed in 135 children, of which 37 (27%) were diagnosed de novo. In all children, both single item and total clinical asthma scores showed a significant increase (p < .001) at the end of the Happy Air® program. The average scores of both the total PedsQL™ 4.0 and the four Scales were significantly increased (p < .001). CONCLUSION: Happy Air® is a model for a strategy of education- and school-based intervention for children with asthma and their families. This multi-action program for diagnosis, clinical follow-up, education, self-management, and quality-of-life control aims to minimize the socioeconomic burden of asthma disease.


Asunto(s)
Asma/diagnóstico , Asma/prevención & control , Educación en Salud , Servicios de Salud Escolar/organización & administración , Instituciones Académicas , Estudiantes , Asma/fisiopatología , Asma/psicología , Niño , Familia , Estado de Salud , Humanos , Calidad de Vida , Índice de Severidad de la Enfermedad , Espirometría
3.
J Allergy Clin Immunol ; 125(3): 727-36, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20153036

RESUMEN

BACKGROUND: Dendritic cells (DCs) regulate the immune response to allergens in the lung; they induce either effector or regulatory T cells, which promote or suppress, respectively, the development of allergy. IL-10 is a potent immunosuppressive cytokine that induces type 1 regulatory (Tr1) T cells. OBJECTIVE: To generate allergen-specific Tr1 cells in vitro from children with allergy. METHODS: Monocyte-derived DCs from children with allergy to house dust mites (HDM) were generated by incubating the cells with IL-10 and pulsing them with Der p 2, a major HDM allergen, or by pulsing them with Der p 2 and incubating them with IL-10 during their last 2 days of differentiation. RESULTS: Der p 2-specific T-cell proliferation and T(H)2 cytokine production were significantly reduced when T cells from patients with allergy to HDM were activated with autologous Der p 2-pulsed DCs that had been differentiated or incubated with IL-10. T-cell lines generated with Der p 2-pulsed DCs that were differentiated with IL-10 were hyporesponsive to reactivation with Der p 2 and able to suppress Der p 2-specific T(H)2 effector cells. CONCLUSION: Dendritic cells differentiated in the presence of IL-10 and pulsed with allergen gave rise to a population of tolerogenic DCs that induced allergen-specific Tr1 cells. This finding represents an important step forward to the prospective clinical application of tolerogenic DCs to modulate allergen-specific T-cell responses.


Asunto(s)
Antígenos Dermatofagoides/inmunología , Diferenciación Celular/inmunología , Células Dendríticas/inmunología , Tolerancia Inmunológica/inmunología , Linfocitos T Reguladores/inmunología , Adolescente , Animales , Proteínas de Artrópodos , Proliferación Celular , Niño , Preescolar , Anergia Clonal/inmunología , Cisteína Endopeptidasas , Citocinas/biosíntesis , Células Dendríticas/citología , Femenino , Humanos , Hipersensibilidad/inmunología , Interleucina-10/inmunología , Activación de Linfocitos/inmunología , Masculino , Pyroglyphidae/inmunología , Linfocitos T Reguladores/citología
4.
Clin Immunol ; 128(3): 322-8, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18708023

RESUMEN

The identification of a Btk mutation in a male patient with <2% CD19(+) B cells warrants making the diagnosis of X-linked Agammaglobulinemia (XLA). Herein we report the case of a 31 year-old male with a gradual decline of peripheral B lymphocytes and low IgA and IgM but normal IgG levels. His clinical history revealed recurrent respiratory and skin infections, sclerosing cholangitis and chronic obstructive pancreatitis. Molecular studies revealed a novel aminoacidic substitution in Btk protein (T316A). His mother, maternal aunts and a maternal female cousin were heterozygotes for the same Btk mutation and were variably affected with pulmonary emphysema. This is a puzzling case where the patient's clinical history and laboratory findings divorce molecular genetics. Either this case confirms the variable expressivity of XLA disease or the T316A change in Btk SH2 domain is a novel non-pathogenic mutation and another unknown gene alteration is responsible for the disease.


Asunto(s)
Agammaglobulinemia/diagnóstico , Agammaglobulinemia/genética , Linfocitos B , Enfermedades Genéticas Ligadas al Cromosoma X/diagnóstico , Subgrupos Linfocitarios/inmunología , Mutación Missense , Proteínas Tirosina Quinasas/genética , Adulto , Agammaglobulinemia Tirosina Quinasa , Agammaglobulinemia/inmunología , Sustitución de Aminoácidos , Linfocitos B/inmunología , Femenino , Enfermedades Genéticas Ligadas al Cromosoma X/inmunología , Enfermedades Genéticas Ligadas al Cromosoma X/metabolismo , Humanos , Recuento de Linfocitos , Subgrupos Linfocitarios/metabolismo , Masculino , Linaje , Proteínas Tirosina Quinasas/química , Proteínas Tirosina Quinasas/metabolismo
6.
Acta Paediatr ; 96(3): 469-71, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17407484

RESUMEN

UNLABELLED: Temporary henna tattoos have become increasingly popular as a safe alternative to permanent tattoos among American and European children and teenagers during the summer holidays. Currently, temporary henna tattoos contain not only henna, but also other additives such as para-phemylenediamine (PPD), which is considered to be the chemical agent that most frequently causes skin reactions associated with the use of commercial black henna. In this report, we describe an 11-year-old boy who applied a temporary black henna tattoo on his right arm during the summer holidays in Greece and developed a severe contact dermatitis at the tattoo site with residual hypopigmentation. He had no previous history of contact dermatitis, however he did suffer from seasonal allergic rhinitis and atopic dermatitis. Patch testing revealed a strong reaction to PPD, a substance commonly contained in temporary henna tattoo preparations. CONCLUSION: Henna tattoos are an increasing problem worldwide since they carry an increased risk of severe skin reactions; therefore we suggest that the use of temporary henna tattoos in children be discouraged.


Asunto(s)
Colorantes/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Naftoquinonas/efectos adversos , Tatuaje/efectos adversos , Niño , Dermatitis Alérgica por Contacto/epidemiología , Dermatitis Alérgica por Contacto/inmunología , Dermatitis Atópica/epidemiología , Humanos , Masculino , Naftoquinonas/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA